MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Tablets are hygroscopic. Contains desiccant therefore unsuitable.

Provenance

This compatibility recommendation is derived from Arava 20mg tablets (Sanofi) and Leflunomide 20mg tablets (Sandoz Ltd).

Stability Notes

Tablets are hygroscopic. Contains desiccant therefore unsuitable.

Provenance

This compatibility recommendation is derived from Arava 20mg tablets (Sanofi) and Leflunomide 20mg tablets (Sandoz Ltd).

Stability Notes

Manufacturer advice available. Max 7 days in MCA.

Provenance

This compatibility recommendation is derived from Arava 20mg tablets (Sanofi) and Leflunomide 20mg tablets (Sandoz Ltd).

Stability Notes

Tablets are hygroscopic. Contains desiccant therefore unsuitable.

Provenance

This compatibility recommendation is derived from Arava 20mg tablets (Sanofi) and Leflunomide 20mg tablets (Sandoz Ltd).

Stability Notes

Tablets are hygroscopic. Contains desiccant therefore unsuitable.

Provenance

This compatibility recommendation is derived from Arava 20mg tablets (Sanofi) and Leflunomide 20mg tablets (Sandoz Ltd).

Stability Notes

Tablets are hygroscopic. Contains desiccant therefore unsuitable.

Provenance

This compatibility recommendation is derived from Arava 20mg tablets (Sanofi) and Leflunomide 20mg tablets (Sandoz Ltd).

Stability Notes

Tablets are hygroscopic. Contains desiccant therefore unsuitable.

Provenance

This compatibility recommendation is derived from Arava 20mg tablets (Sanofi) and Leflunomide 20mg tablets (Sandoz Ltd).

Stability Notes

Tablets are hygroscopic. Contains desiccant therefore unsuitable.

Provenance

This compatibility recommendation is derived from Arava 20mg tablets (Sanofi) and Leflunomide 20mg tablets (Sandoz Ltd).

Stability Notes

Tablets are hygroscopic. Contains desiccant therefore unsuitable.

Provenance

This compatibility recommendation is derived from Arava 20mg tablets (Sanofi) and Leflunomide 20mg tablets (Sandoz Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.